• Vittia’s third-quarter 2026 adjusted net income fell 24% year over year to BRL 39.16 million.
• Nine-month adjusted EBITDA dropped 27% year over year to BRL 50.84 million, primarily due to lower gross profit.
• The biotechnology and plant-nutrition business launched four products in 2026, expanding its biological protection, biostimulation and plant-nutrition portfolio.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vittia SA published the original content used to generate this news brief on November 11, 2026, and is solely responsible for the information contained therein.